1,5-DIMETHYL 3-((((3R,5R)-3-BUTYL-3-ETHYL-2,3,4,5-TETRAHYDRO-7-METHOXY-1,1-DIOXIDO-5-PHENYL-1,4-BENZOTHIAZEPIN-8-YL)METHYL)AMINO)PENTANEDIOATE
UNII 8E9CGN9EC9
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,5-dimethyl 3-((((3r,5r)-3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl)methyl)amino)pentanedioate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8E9CGN9EC9.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1345983-90-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C30H42N2O7S JYHWBQWYGJFGFO-LOYHVIPDSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,5-dimethyl 3-((((3r,5r)-3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl)methyl)amino)pentanedioate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.